# Ratio Therapeutics funding: rounds and investors

> Ratio Therapeutics has raised $70M across 1 round since 2026. Investors include Eli Lilly and Catalio Capital Management. Every round with its source.

Source: https://millionrounds.com/company/ratio-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Series C startup](https://millionrounds.com/companies)

# Who invested in *Ratio Therapeutics*

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 4 months ago

Funding summary Updated 26 Oct 2026

**$70M** raised across 1 round since 2026, from 1 source

- **Latest round:** Series C, $70M Jul 2026
- **Investors:** 2

See who backed them

## The rounds

- **Jul 2026** Series C **$70M** [Eli Lilly](https://millionrounds.com/fund/eli-lilly) [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) Source recorded SEC filing: $70M sold

## Everyone who backed them

[Eli Lilly](https://millionrounds.com/fund/eli-lilly) Corporate VC **1** round

[Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=ratio-therapeutics).

## Quick answers about Ratio Therapeutics

### Who invested in Ratio Therapeutics?

Ratio Therapeutics's investors include Eli Lilly and Catalio Capital Management.

### How much has Ratio Therapeutics raised?

Ratio Therapeutics has raised $70M across 1 round since 2026.

### When did Ratio Therapeutics last raise?

Ratio Therapeutics's most recent round was a Series C of $70M in Jul 2026.

### What was Ratio Therapeutics's biggest round?

Its most recent round, $70M in Jul 2026, is also its largest on record.

### Who backed Ratio Therapeutics first?

Ratio Therapeutics's first round on record, in Jul 2026, was backed by Eli Lilly and Catalio Capital Management.

### What stage is Ratio Therapeutics at?

Ratio Therapeutics's latest named round is a Series C, in Jul 2026.

### Where is Ratio Therapeutics based?

Ratio Therapeutics is based in the United States.

## Companies like Ratio Therapeutics

In the same sector, and raised in the last eighteen months.

[**Matchpoint Therapeutics** $220M · Oct 2026](https://millionrounds.com/company/matchpoint-therapeutics)[**Rx Bandz** Oct 2026](https://millionrounds.com/company/rx-bandz)[**Hera Biotech** $1.8M · Sept 2026](https://millionrounds.com/company/hera-biotech)[**GevRx Nutraceuticals** $300K · Sept 2026](https://millionrounds.com/company/gevrx-nutraceuticals)[**RegCell** $81M · Sept 2026](https://millionrounds.com/company/regcell)[**ClearSight Therapeutics** $307K · Sept 2026](https://millionrounds.com/company/clearsight-therapeutics)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app